FindTrial
Sign In

Study on Abacavir drug hypersensitivity among HIV infected adult patients

Screening for Abacavir Hypersensitivity by DNA Microarray among HIV sero-positive adult patients in a tertiary care hospital

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/07/020202
Enrollment
52
Registered
2019-07-15
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B20- Human immunodeficiency virus [HIV]disease

Interventions

None listed

Sponsors

Manipal McGill Center for Infectious Diseases
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with HIV infection of both the gender and above 18 years of age presenting to the HIV clinic, Kasturba Hospital Manipal will be included in the study.

Exclusion criteria

Exclusion criteria: HIV infected children below 18 years of age will be excluded from the study.

Design outcomes

Primary

MeasureTime frame
This study will help in obtaining the frequency of HIV infected patients carrying HLA-B57:01 allele in our setting. This would help in predicting those individuals who are susceptible to develop abacavir HSR.Timepoint: July 2019 - June 2020—

Secondary

MeasureTime frame
To document the usage of abacavir based anti-retroviral treatment regimens and their adverse effect profile in the HIV clinic.Timepoint: July 2019 - June 2020—

Countries

India

Contacts

Public ContactShashidhar V

Kasturba Medical College Manipal

shashidhar.v@manipal.edu9886075904

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026